Get started
Author

Kiyoko Yamada

Observed name: Kiyoko YAMADA
ORCID: 0009-0006-8314-7260
Observed ORCID: 0009-0006-8314-7260
OpenAlex ID: A5058805705
A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab
2024 · Kiyoko Yamada, Atsunori Baba, et al. · Journal of the European Academy of Dermatology and Venereology · 7
Cutaneous adverse events following COVID‐19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies
2024 · Atsunori Baba, Kiyoko Yamada, et al. · The Journal of Dermatology · 5
PDF
High concentration of glucose induces filaggrin-1 expression through AP-1 in skin keratinocytes
2020 · Masae Furukawa, Kiyoko Yamada, et al. · Journal of Dermatological Science · 5
Sister Mary Joseph’s Nodule Case Diagnosed of Primary Peritoneal Cancer
2026 · Kiyoko YAMADA, Junichi NAKAZAWA, et al. · The Nishinihon Journal of Dermatology
A Case of Bullous Pemphigoid That Worsened After Administration of Nemolizumab
2025 · Kiyoko YAMADA, Kazunobu SUEYOSHI, et al. · The Nishinihon Journal of Dermatology
High glucose activates claudin-1 and filaggrin expression: Possible mechanism of the antiinflammatory effect by repairing the skin barrier
2017 · Kiyoko Yamada · Journal of Dermatological Science
Molecular mechanism by which topical application of high glucose repairs skin damage: Induction of Filaggrin and Claudin-1 expression
2016 · Jingshu Wang, Kiyoko Yamada, et al. · The Molecular Biology Society of Japan
High concentration of glucose activates migration and proliferation of human skin keratinocytes through inducing active release of HMGB1
2013 · Kiyoko Yamada, Kenji Matsushita · Journal of Investigative Dermatology
PDF
Works count: 8
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type